Investment Stage

Focus Areas

About Investor

Florent Gros is a Venture Partner at Earlybird Venture Capital, where he focuses on investments in Pharmaceuticals, BioTech, Health IT, Health & Hospital Services, Diagnostics, and Digital Health companies at Seed, Series A, and Series B stages with an investment range of $100K - $5.0M. Gros joined Earlybird Health as a Partner in 2020, bringing 28 years of expertise in investment and intellectual property management in the biopharma space. With a background in biotechnology, patent and private law, and a Kauffman Fellowship, he spent 15 years at the Novartis Venture Fund, where he seeded, invested in, and managed numerous startups. Gros has also founded three biotech companies, including Handl Therapeutics, which was sold in 2020, and is based in Berlin, Germany.